A minority shareholder of Shandong Buchang Pharmaceuticals (SHA:603858) subsidiary Hangzhou Buchang Jianxin will sell his entire 2% stake to a sales director at the same unit, according to a Wednesday filing with the Shanghai bourse.
Li Bin will sell the stake for 55,558 yuan to Yi Cui, the sales director at the subsidiary's Qibai Brand Department.